Parametric Portfolio Associates’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Parametric Portfolio Associates’s Portfolio NGM Stock Details NGM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$269K	Sell	17,629 -857	-5%	-$13.4K	﹤0.01%	3327
2021 Q4	$327K	Sell	18,486 -13,255	-42%	-$254K	﹤0.01%	3249
2021 Q3	$667K	Buy	31,741 +2,429	+8%	+$53.5K	﹤0.01%	2973
2021 Q2	$578K	Sell	29,312 -18,330	-38%	-$429K	﹤0.01%	3020
2021 Q1	$1.39M	Buy	47,642 +12,156	+34%	+$340K	﹤0.01%	2993
2020 Q4	$1.07M	Sell	35,486 -1,545	-4%	-$33.8K	﹤0.01%	3016
2020 Q3	$589K	Sell	37,031 -317	-0.8%	-$5.78K	﹤0.01%	3193
2020 Q2	$737K	Sell	37,348 -805	-2%	-$15.4K	﹤0.01%	3083
2020 Q1	$470K	Buy	38,153 +22,213	+139%	+$363K	﹤0.01%	3191
2019 Q4	$295K	Sell	15,940 -3,388	-18%	-$49.5K	﹤0.01%	3574
2019 Q3	$268K	Buy	+19,328	New	+$290K	﹤0.01%	3596

Other funds holding NGM

Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

Rho Capital Partners New York $20.4M AUM

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return

Ponoi II Management San Francisco, California $38.3M AUM 32.02% 1-Year Est. Return

Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return